| Ronald Mark Guy, MD | |
|
4141 5th St, Rapid City, SD 57701-6021 | |
| (605) 791-0602 | |
| (605) 791-0978 |
| Full Name | Ronald Mark Guy |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 38 Years |
| Location | 4141 5th St, Rapid City, South Dakota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1881651057 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | 19986 (Oklahoma) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Monument Health Rapid City Hospital | Rapid city, SD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Monument Health Rapid City Hospital, Inc. | 6002729506 | 424 |
News Archive
New international guidelines published in the journal Transplantation reinforce the use of a new type of blood test to assess cytomegalovirus (CMV) risk in solid organ transplant recipients (i.e. transplant recipients). This blood test, QuantiFERON®-CMV (QF-CMV), is the first commercially-available blood test to allow physicians to monitor a person's risk of CMV disease. Most commonly used in the transplant setting, QF-CMV may predict which transplant recipients are at increased risk of CMV disease after transplant surgery.
Cerus Corporation announced today that investigators from blood centers in Sweden, Belgium, France and Slovenia will present their experience with the INTERCEPT Blood System for platelets and plasma during a leading international transfusion safety meeting, the XIIth International Haemovigilance Seminar taking place in Dubrovnik, Croatia from February 17 to 19.
A new study led by researchers at the UCLA Jonsson Comprehensive Cancer Center helps identify which patients with prostate cancer will benefit most from the use of prostate-specific membrane antigen PET imaging, PSMA PET, a novel imaging technique that recently was approved by the U.S. Food and Drug Administration.
Politico: "Senate Finance Committee Chairman Max Baucus faces multiple challenges as he gavels in another week of work on health care Tuesday. High on the list: controlling the drama in the hearing room."
› Verified 4 days ago
| Entity Name | Black Hills Surgical Hospital Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972630275 PECOS PAC ID: 5496742835 Enrollment ID: O20050616000485 |
News Archive
New international guidelines published in the journal Transplantation reinforce the use of a new type of blood test to assess cytomegalovirus (CMV) risk in solid organ transplant recipients (i.e. transplant recipients). This blood test, QuantiFERON®-CMV (QF-CMV), is the first commercially-available blood test to allow physicians to monitor a person's risk of CMV disease. Most commonly used in the transplant setting, QF-CMV may predict which transplant recipients are at increased risk of CMV disease after transplant surgery.
Cerus Corporation announced today that investigators from blood centers in Sweden, Belgium, France and Slovenia will present their experience with the INTERCEPT Blood System for platelets and plasma during a leading international transfusion safety meeting, the XIIth International Haemovigilance Seminar taking place in Dubrovnik, Croatia from February 17 to 19.
A new study led by researchers at the UCLA Jonsson Comprehensive Cancer Center helps identify which patients with prostate cancer will benefit most from the use of prostate-specific membrane antigen PET imaging, PSMA PET, a novel imaging technique that recently was approved by the U.S. Food and Drug Administration.
Politico: "Senate Finance Committee Chairman Max Baucus faces multiple challenges as he gavels in another week of work on health care Tuesday. High on the list: controlling the drama in the hearing room."
› Verified 4 days ago
| Entity Name | Monument Health Rapid City Hospital, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275553463 PECOS PAC ID: 6002729506 Enrollment ID: O20070625000144 |
News Archive
New international guidelines published in the journal Transplantation reinforce the use of a new type of blood test to assess cytomegalovirus (CMV) risk in solid organ transplant recipients (i.e. transplant recipients). This blood test, QuantiFERON®-CMV (QF-CMV), is the first commercially-available blood test to allow physicians to monitor a person's risk of CMV disease. Most commonly used in the transplant setting, QF-CMV may predict which transplant recipients are at increased risk of CMV disease after transplant surgery.
Cerus Corporation announced today that investigators from blood centers in Sweden, Belgium, France and Slovenia will present their experience with the INTERCEPT Blood System for platelets and plasma during a leading international transfusion safety meeting, the XIIth International Haemovigilance Seminar taking place in Dubrovnik, Croatia from February 17 to 19.
A new study led by researchers at the UCLA Jonsson Comprehensive Cancer Center helps identify which patients with prostate cancer will benefit most from the use of prostate-specific membrane antigen PET imaging, PSMA PET, a novel imaging technique that recently was approved by the U.S. Food and Drug Administration.
Politico: "Senate Finance Committee Chairman Max Baucus faces multiple challenges as he gavels in another week of work on health care Tuesday. High on the list: controlling the drama in the hearing room."
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ronald Mark Guy, MD 4141 5th St, Rapid City, SD 57701-6021 Ph: (605) 791-0602 | Ronald Mark Guy, MD 4141 5th St, Rapid City, SD 57701-6021 Ph: (605) 791-0602 |
News Archive
New international guidelines published in the journal Transplantation reinforce the use of a new type of blood test to assess cytomegalovirus (CMV) risk in solid organ transplant recipients (i.e. transplant recipients). This blood test, QuantiFERON®-CMV (QF-CMV), is the first commercially-available blood test to allow physicians to monitor a person's risk of CMV disease. Most commonly used in the transplant setting, QF-CMV may predict which transplant recipients are at increased risk of CMV disease after transplant surgery.
Cerus Corporation announced today that investigators from blood centers in Sweden, Belgium, France and Slovenia will present their experience with the INTERCEPT Blood System for platelets and plasma during a leading international transfusion safety meeting, the XIIth International Haemovigilance Seminar taking place in Dubrovnik, Croatia from February 17 to 19.
A new study led by researchers at the UCLA Jonsson Comprehensive Cancer Center helps identify which patients with prostate cancer will benefit most from the use of prostate-specific membrane antigen PET imaging, PSMA PET, a novel imaging technique that recently was approved by the U.S. Food and Drug Administration.
Politico: "Senate Finance Committee Chairman Max Baucus faces multiple challenges as he gavels in another week of work on health care Tuesday. High on the list: controlling the drama in the hearing room."
› Verified 4 days ago
Robert Burgess, Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 101 E Minnesota St, Suite 210, Rapid City, SD 57701 Phone: 605-342-3280 | |
Jay W. White, DO Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 101 E Minnesota St, Suite 210, Rapid City, SD 57701 Phone: 605-342-3280 Fax: 605-721-8458 | |
Dallin N Christensen, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 241 Minnesota St, Rapid City, SD 57701 Phone: 605-791-0602 | |
Robert Ferrell, Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 2820 Mount Rushmore Rd, Rapid City, SD 57701 Phone: 605-342-3280 | |
Troy Benjamin Howard, Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 101 E Minnesota St, Suite 210, Rapid City, SD 57701 Phone: 605-342-3280 | |
Vaughan Richard Bowen, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 4447 S Canyon Rd Ste 6, Rapid City, SD 57702 Phone: 605-716-0548 Fax: 605-716-0447 | |
Jack Robert Schleiffarth, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 4940 5th St Ste 2b, Rapid City, SD 57701 Phone: 605-791-0602 Fax: 605-791-0978 |